Corum Group Limited
Corum Group Limited (COO.AX) Stock Competitors & Peer Comparison
See (COO.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| COO.AX | A$0.04 | +2.33% | 26.3M | N/A | N/A | N/A |
| PME.AX | A$313.99 | -2.45% | 32.8B | 337.62 | A$0.93 | +0.15% |
| CGS.AX | A$1.74 | +0.58% | 294.6M | 24.79 | A$0.07 | N/A |
| VHT.AX | A$1.15 | +0.44% | 291.3M | -28.63 | -A$0.04 | N/A |
| ONE.AX | A$0.25 | +0.00% | 185.7M | -8.17 | -A$0.03 | N/A |
| ALC.AX | A$0.12 | +4.35% | 161.2M | -12.00 | -A$0.01 | N/A |
| AYA.AX | A$0.98 | -4.39% | 111.6M | -5.44 | -A$0.18 | N/A |
| SHG.AX | A$0.32 | +5.00% | 95M | -15.75 | -A$0.02 | N/A |
| M7T.AX | A$0.37 | -2.63% | 86.9M | -18.50 | -A$0.02 | N/A |
| BMT.AX | A$0.26 | +6.12% | 75.5M | -13.00 | -A$0.02 | N/A |
Stock Comparison
COO.AX vs PME.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, PME.AX has a market cap of 32.8B. Regarding current trading prices, COO.AX is priced at A$0.04, while PME.AX trades at A$313.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas PME.AX's P/E ratio is 337.62. In terms of profitability, COO.AX's ROE is -0.05%, compared to PME.AX's ROE of +0.48%. Regarding short-term risk, COO.AX is less volatile compared to PME.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check PME.AX's competition here
COO.AX vs CGS.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, CGS.AX has a market cap of 294.6M. Regarding current trading prices, COO.AX is priced at A$0.04, while CGS.AX trades at A$1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas CGS.AX's P/E ratio is 24.79. In terms of profitability, COO.AX's ROE is -0.05%, compared to CGS.AX's ROE of +0.20%. Regarding short-term risk, COO.AX is less volatile compared to CGS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check CGS.AX's competition here
COO.AX vs VHT.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, VHT.AX has a market cap of 291.3M. Regarding current trading prices, COO.AX is priced at A$0.04, while VHT.AX trades at A$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas VHT.AX's P/E ratio is -28.63. In terms of profitability, COO.AX's ROE is -0.05%, compared to VHT.AX's ROE of -0.18%. Regarding short-term risk, COO.AX is less volatile compared to VHT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check VHT.AX's competition here
COO.AX vs ONE.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, ONE.AX has a market cap of 185.7M. Regarding current trading prices, COO.AX is priced at A$0.04, while ONE.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas ONE.AX's P/E ratio is -8.17. In terms of profitability, COO.AX's ROE is -0.05%, compared to ONE.AX's ROE of -1.17%. Regarding short-term risk, COO.AX is less volatile compared to ONE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check ONE.AX's competition here
COO.AX vs ALC.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, ALC.AX has a market cap of 161.2M. Regarding current trading prices, COO.AX is priced at A$0.04, while ALC.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas ALC.AX's P/E ratio is -12.00. In terms of profitability, COO.AX's ROE is -0.05%, compared to ALC.AX's ROE of -0.06%. Regarding short-term risk, COO.AX is less volatile compared to ALC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check ALC.AX's competition here
COO.AX vs AYA.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, AYA.AX has a market cap of 111.6M. Regarding current trading prices, COO.AX is priced at A$0.04, while AYA.AX trades at A$0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas AYA.AX's P/E ratio is -5.44. In terms of profitability, COO.AX's ROE is -0.05%, compared to AYA.AX's ROE of -0.92%. Regarding short-term risk, COO.AX is less volatile compared to AYA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check AYA.AX's competition here
COO.AX vs SHG.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, SHG.AX has a market cap of 95M. Regarding current trading prices, COO.AX is priced at A$0.04, while SHG.AX trades at A$0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas SHG.AX's P/E ratio is -15.75. In terms of profitability, COO.AX's ROE is -0.05%, compared to SHG.AX's ROE of -0.80%. Regarding short-term risk, COO.AX is less volatile compared to SHG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check SHG.AX's competition here
COO.AX vs M7T.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, M7T.AX has a market cap of 86.9M. Regarding current trading prices, COO.AX is priced at A$0.04, while M7T.AX trades at A$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas M7T.AX's P/E ratio is -18.50. In terms of profitability, COO.AX's ROE is -0.05%, compared to M7T.AX's ROE of -0.10%. Regarding short-term risk, COO.AX is less volatile compared to M7T.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check M7T.AX's competition here
COO.AX vs BMT.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, BMT.AX has a market cap of 75.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while BMT.AX trades at A$0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas BMT.AX's P/E ratio is -13.00. In terms of profitability, COO.AX's ROE is -0.05%, compared to BMT.AX's ROE of -0.12%. Regarding short-term risk, COO.AX is less volatile compared to BMT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check BMT.AX's competition here
COO.AX vs PCK.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, PCK.AX has a market cap of 64.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while PCK.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas PCK.AX's P/E ratio is -3.50. In terms of profitability, COO.AX's ROE is -0.05%, compared to PCK.AX's ROE of -4.53%. Regarding short-term risk, COO.AX is less volatile compared to PCK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check PCK.AX's competition here
COO.AX vs DOC.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, DOC.AX has a market cap of 49.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while DOC.AX trades at A$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas DOC.AX's P/E ratio is -4.50. In terms of profitability, COO.AX's ROE is -0.05%, compared to DOC.AX's ROE of -5.56%. Regarding short-term risk, COO.AX is less volatile compared to DOC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check DOC.AX's competition here
COO.AX vs MDR.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, MDR.AX has a market cap of 43.8M. Regarding current trading prices, COO.AX is priced at A$0.04, while MDR.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas MDR.AX's P/E ratio is -7.00. In terms of profitability, COO.AX's ROE is -0.05%, compared to MDR.AX's ROE of -0.09%. Regarding short-term risk, COO.AX is less volatile compared to MDR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check MDR.AX's competition here
COO.AX vs EMD.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, EMD.AX has a market cap of 28.1M. Regarding current trading prices, COO.AX is priced at A$0.04, while EMD.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas EMD.AX's P/E ratio is -1.53. In terms of profitability, COO.AX's ROE is -0.05%, compared to EMD.AX's ROE of -0.56%. Regarding short-term risk, COO.AX is less volatile compared to EMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check EMD.AX's competition here
COO.AX vs RHT.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, RHT.AX has a market cap of 17.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while RHT.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas RHT.AX's P/E ratio is N/A. In terms of profitability, COO.AX's ROE is -0.05%, compared to RHT.AX's ROE of -0.03%. Regarding short-term risk, COO.AX is less volatile compared to RHT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check RHT.AX's competition here
COO.AX vs IME.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, IME.AX has a market cap of 16.1M. Regarding current trading prices, COO.AX is priced at A$0.04, while IME.AX trades at A$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas IME.AX's P/E ratio is -5.00. In terms of profitability, COO.AX's ROE is -0.05%, compared to IME.AX's ROE of -0.18%. Regarding short-term risk, COO.AX is less volatile compared to IME.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check IME.AX's competition here
COO.AX vs 1ST.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, 1ST.AX has a market cap of 15.6M. Regarding current trading prices, COO.AX is priced at A$0.04, while 1ST.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas 1ST.AX's P/E ratio is -1.10. In terms of profitability, COO.AX's ROE is -0.05%, compared to 1ST.AX's ROE of +0.69%. Regarding short-term risk, COO.AX and 1ST.AX have similar daily volatility (0.00).Check 1ST.AX's competition here
COO.AX vs HIQ.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, HIQ.AX has a market cap of 9.8M. Regarding current trading prices, COO.AX is priced at A$0.04, while HIQ.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas HIQ.AX's P/E ratio is -2.10. In terms of profitability, COO.AX's ROE is -0.05%, compared to HIQ.AX's ROE of +2.49%. Regarding short-term risk, COO.AX and HIQ.AX have similar daily volatility (0.00).Check HIQ.AX's competition here
COO.AX vs ICR.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, ICR.AX has a market cap of 5.9M. Regarding current trading prices, COO.AX is priced at A$0.04, while ICR.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas ICR.AX's P/E ratio is -1.20. In terms of profitability, COO.AX's ROE is -0.05%, compared to ICR.AX's ROE of -10.86%. Regarding short-term risk, COO.AX is less volatile compared to ICR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check ICR.AX's competition here
COO.AX vs OPL.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, OPL.AX has a market cap of 5.7M. Regarding current trading prices, COO.AX is priced at A$0.04, while OPL.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas OPL.AX's P/E ratio is -2.30. In terms of profitability, COO.AX's ROE is -0.05%, compared to OPL.AX's ROE of +12.65%. Regarding short-term risk, COO.AX is less volatile compared to OPL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check OPL.AX's competition here
COO.AX vs MEB.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, MEB.AX has a market cap of 4.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while MEB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas MEB.AX's P/E ratio is -0.10. In terms of profitability, COO.AX's ROE is -0.05%, compared to MEB.AX's ROE of -0.47%. Regarding short-term risk, COO.AX is less volatile compared to MEB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for COO.AX.Check MEB.AX's competition here
COO.AX vs GLH.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, GLH.AX has a market cap of 4.5M. Regarding current trading prices, COO.AX is priced at A$0.04, while GLH.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas GLH.AX's P/E ratio is -7.60. In terms of profitability, COO.AX's ROE is -0.05%, compared to GLH.AX's ROE of +0.27%. Regarding short-term risk, COO.AX and GLH.AX have similar daily volatility (0.00).Check GLH.AX's competition here
COO.AX vs TD1.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, TD1.AX has a market cap of 4.2M. Regarding current trading prices, COO.AX is priced at A$0.04, while TD1.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas TD1.AX's P/E ratio is -0.10. In terms of profitability, COO.AX's ROE is -0.05%, compared to TD1.AX's ROE of -0.24%. Regarding short-term risk, COO.AX and TD1.AX have similar daily volatility (0.00).Check TD1.AX's competition here
COO.AX vs CTQ.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, CTQ.AX has a market cap of 2.8M. Regarding current trading prices, COO.AX is priced at A$0.04, while CTQ.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas CTQ.AX's P/E ratio is -1.20. In terms of profitability, COO.AX's ROE is -0.05%, compared to CTQ.AX's ROE of -0.62%. Regarding short-term risk, COO.AX and CTQ.AX have similar daily volatility (0.00).Check CTQ.AX's competition here
COO.AX vs OAK.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, OAK.AX has a market cap of 1.8M. Regarding current trading prices, COO.AX is priced at A$0.04, while OAK.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas OAK.AX's P/E ratio is -1.67. In terms of profitability, COO.AX's ROE is -0.05%, compared to OAK.AX's ROE of -0.44%. Regarding short-term risk, COO.AX and OAK.AX have similar daily volatility (0.00).Check OAK.AX's competition here
COO.AX vs JTL.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, JTL.AX has a market cap of 281.3K. Regarding current trading prices, COO.AX is priced at A$0.04, while JTL.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas JTL.AX's P/E ratio is -0.10. In terms of profitability, COO.AX's ROE is -0.05%, compared to JTL.AX's ROE of +0.60%. Regarding short-term risk, COO.AX and JTL.AX have similar daily volatility (0.00).Check JTL.AX's competition here
COO.AX vs TTB.AX Comparison August 2025
COO.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO.AX stands at 26.3M. In comparison, TTB.AX has a market cap of 267.4K. Regarding current trading prices, COO.AX is priced at A$0.04, while TTB.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO.AX currently has a P/E ratio of N/A, whereas TTB.AX's P/E ratio is -0.02. In terms of profitability, COO.AX's ROE is -0.05%, compared to TTB.AX's ROE of -1.05%. Regarding short-term risk, COO.AX and TTB.AX have similar daily volatility (0.00).Check TTB.AX's competition here